INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 January 2016
|
Net Assets |
£194m |
|
Net Assets per share |
493p |
|
Share price |
430p |
|
Total value of unquoted investments |
£22m |
|
Total number of portfolio companies |
86 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
8.5 |
|
Biogen |
8.5 |
|
Celgene |
8.1 |
|
Gilead |
7.0 |
|
Regeneron |
6.6 |
|
Alexion |
3.7 |
|
Genmab |
3.7 |
|
Vertex |
2.9 |
|
Ophthotech |
2.9 |
|
Chimerix |
2.6 |
|
|
----------- |
|
Total |
54.5 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
57 |
|
Turning Profitable 2016 |
6 |
|
Unprofitable |
37 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
85 |
|
Europe & UK |
15 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
89 |
|
Unquoted |
11 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
12 FEBRUARY 2016